GoldNApel FB Update!! GoldNApel 10/10/2013. Hi

New Post Public Reply Private Reply Replies (6) Message Board
on41greyst
GoldNApel FB Update!!

GoldNApel 10/10/2013.

Hi Everybody,

I have been carrying on a conversation with Chris on the facebook message feature. He recently inquired if we were still active because he hadn't heard from me for a few days, as we were quite busy. I wrote him a long reply and realized that it might be good to share it with everyone. Here it is:

Hi Chris,

Yes we are active and we have been working very hard. Sorry I was slow in replying. That time of the year! Harvest time for a strain of Cannatonic that yielded over 17% CBD several years back. Waiting for tests on this year's efforts. Hopefully we have the THC down to near nothing, but actually, it doesn't matter all that much anymore. We can now preserve all of the cannabinoids in their non-psychoactive form with the new technology that Dr. Apel has developed over the last year or so, and that we announced today.

The "game-changer" we talked about a while back is here. I really believe that our new Dharmanol preparation will enable a cancer patient to take 10 or more times the cannabinoids that are recommended in Simpson therapy, and there may well be no cancer that can stand up to this kind of treatment in an otherwise-healthy individual. Everything we have seen in this field of research indicates that this may well be true.

I will never claim a "cure" until we have some double-blind placebo-controlled tests of the type Dr. Abrams wants to do, if the government would ever give him some "official" cannabis oil to experiment with, but even a person with no formal education in science can go online, google keywords like "cannabis cancer" and do many hours of informative reading from reputable scientific sources.

I would think that anyone with an interest in what SK3 and BBio are doing would perform this simple task and see what the current research is saying. Even the staunchest skeptic, with a bit of reading and study, would likely agree that cannabinoid therapy is indeed a treatment for cancer that holds a great deal of promise for mankind. That is why I find it so hard to believe that there are those who try so hard to question everything that we are doing, and present all of our activities in the worst possible light on the message boards.

(By the way, I will scan the boards on a day such as today, but all of us are far too busy building our respective parts of this company to put much time and effort into the boards).

Several months ago I said that I would answer any questions here that I could from those who speculate on the message boards, and I appreciate your starting a conversation with me, but I have received very few questions.

The announcement today was just a part of where we see this going. We now have the capacity to remove the psychoactivity from the kind herb, and make it truly a kind medicine, for all of those in need of healing. There are several different delivery systems we are working on, as well as combinations with other healing herbs and supplements, providing Dharmanol-based medicines tailored specifically for a variety of the ailments that cannabinoid therapy has shown to be effective in treating.

Thanks again for the conversation. I will always do my best to keep a good dialogue going.

Dave

While I'm at it, let me clarify low-dose and high-dose Dharmanol. The low-dose tablets are designed for daily health maintenance with a total of 10 mg. of cannabinoids, consisting of 5 mg. CBD and 5 mg. mixed cannabinoid carboxylates (which have been stabilized in their non-psychoactive form), and an additional 5 mg of steam-extracted terpenes and terpenoids from a variety of strains of cannabis. (The terpenes help the cannabinoids bind to the receptors, enhancing the efficacy of the treatment). Also, the steam-extract allows the extraction and inclusion of many different elements of the kind herb which have demonstrated that so-called whole plant medicinals are much better than just the isolated elements, in many cases, and utilizing an extract from the widest variety of strains possible insures that we get some of the entire spectrum of whole-plant goodness.

The purpose of high-dose Dharmanol is to provide the body of a cancer patient with the equivalent of a Simpson dose, but without the psychoactivity or "high". A different delivery system is being prepared for utilizing Dharmanol in high doses for the treatment of serious illnesses, but it is not inconceivable for a person treating cancer to chew 8 low-dose Dharmanol tablets six times a day, which would give a Simpson-sized dose with no side effects, and, in strictly my own opinion, the safest and most promising experimental cancer treatment that is currently being studied in the world of cannabis science.

The ultimate hope for Dharmanol will come in mega-doses that exceed the Simpson norm many times. Simpson's recommended dose is about one ten-thousandth of the LD-50 for marijuana. (LD-50 is the amount of a drug that will kill half of the lab animals to which it is administered). Most cancer drugs are so harmful to the body that the effective dose is a large percentage of the size dose that will cause death.

With the huge ratio between the Simpson dose and the LD-50 for cannabis, there is opportunity to step up the dosage levels many times. The only reason this isn't done is because handling a full gram of strong cannabis oil daily is very difficult for many people, especially by those who have never experienced cannabis. Now that we have removed the psychoactivity and medicinalized the plant, we will soon see the results of people treating serious illnesses with many times the doses possible today.

Cannabis medicine works on both ends of the spectrum. Small daily doses will tune up the body's own endo-cannabinoid system, keeping one healthy. Large doses are doseage-dependent, meaning the more the better. University lab tests have shown that concentrated cannabis medicine, when applied to cancerous tissue, adjacent to healthy tissue, will directly kill the malignant cells, while simultaneously strengthening the healthy ones. Even though there are many other mechanisms that cannabis uses to fight disease, I find this one amazing, and indicative of the special energy that this wonderful plant holds.

Thanks!

Dave

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Restorative Getaways Aid Grieving Families, Offers Relief

Updated Category News Views 71

Finding Solace in Change: The Power of Stepping Away Grieving a lost child. It’s a trip to hell and back, and for many families, the journey feels endless. The press of everyday life—bills, jobs, commutes—offers no mercy. At times, stepping out of the blur might be the prime move toward healing, and that's where restorative getaways step in. Escaping the Everyday...

Continue Reading
Syra Health Hits Record Revenue, Sustains Growth

Updated Category News Views 0

Syra Health Reports Stellar Q3 Performance Folks, let's dive right into the figures: Syra Health's Q3 2026 performance is nothing short of a powerhouse display. We're talking about a jaw-dropping 52% surge in revenue compared to the same period last year, climbing to a record $2.6 million. It's not often you see a company swing its EPS from a loss of $(0.02) to a positive...

Continue Reading
Extreme Weather Survivors Rally for Change with 'Stolen Summers'

Updated Category News Views 62

Lighting a Fire Under Complacency Elections often bring out the big dogs, but rarely do you see a grassroots campaign like Extreme Weather Survivors’ 'Stolen Summers' making such ripples. Rallying from New York to North Carolina and everywhere in between, this campaign has been a clarion call for communities ravaged by Mother Nature's fury. And let's face it, the...

Continue Reading
New Xavier Ochsner College of Medicine Opens Applications

Updated Category News Views 12

Paving New Paths in Medical Education Out of the vibrant hub of New Orleans comes a fresh twist in the world of medical education: the Xavier Ochsner College of Medicine is now taking applications for its 2027 debut class. The key here is a powerhouse collaboration between Xavier University of Louisiana and Ochsner Health. These are big names in their own right,...

Continue Reading
Rana Gillmon Takes on Bigger Role at AXA XL

Updated Category News Views 42

Leadership Leap for Rana Gillmon Well, we've got some buzz from AXA XL that's stirring the pot in the insurance scene, with Rana Gillmon taking on a more expansive role. She's now at the helm of client and distribution activities in the East Zone of the U.S. alongside her existing responsibilities in private equity client relations across the Americas. Sounds like a hefty...

Continue Reading
Grupo Bimbo Climbs Rankings as Top Global Employer

Updated Category News Views 113

Grupo Bimbo’s Big Leap on the Global Stage Cranking out a solid rise in reputation, Grupo Bimbo has jumped up 107 positions to seize the 444th spot in the 2026 Forbes 'World's Best Employers' list. This isn't just a one-off headline-grabber; it's a testament to the serious work going on behind the scenes at this baking giant. Clawing its way higher from rank 551 in the...

Continue Reading
Life Time & Dewitt Carolinas Unveil Raleigh's Bold Future

Updated Category News Views 142

Shaping the Skyline with Life Time Living Right in the heart of Midtown Raleigh, they're drawing lines in the sand for what the future of upscale living will look like. On October 29, Dewitt Carolinas and Life Time (NYSE: LTH) officially broke ground on Life Time Living at The Exchange Raleigh. Sure, groundbreaking ceremonies happen all the time, but this one sends a...

Continue Reading
Scientific Games Dives Into Omnichannel Lottery Future

Updated Category News Views 23

Scientific Games Breaks New Ground at WLS 2026 Innovation isn't about resting on your laurels, and boy, does Scientific Games know it. At the World Lottery Summit in Sydney this November, they're showcasing a buffet of cutting-edge games and technology aimed at revolutionizing the lottery landscape. But hey, this ain't just about flashy lights and digital frills –...

Continue Reading
Steven Johnson Boosts Latham's Tax Team in D.C.

Updated Category News Views 69

Another Day, Another Big Hire in D.C. You'd think the revolving doors at these law firms were tied to Wall Street's cycles. Latham & Watkins, one heavyweight in the legal arena, is pulling a classic power move, snapping up Steven Johnson for their Washington, D.C. office. He ain't just some guy off the street; Johnson's got a résumé that reads like a textbook on federal...

Continue Reading
Why Renters Insurance is a Must for Tenants

Updated Category News Views 122

Diving Into Renters Insurance: What You Need to Know Renters insurance isn't just another unnecessary add-on; it's practically a necessity if you're renting. Joseph Puckett, of Golseth and Puckett Agency: Allstate Insurance, gives us the lowdown on the essential protection renters need but often overlook. The Myth and the Reality Ah, the age-old misconception—many...

Continue Reading

Top 5 Most Recently Viewed Articles

Wells Fargo Boosts monday.com Rating Amid Strong Growth Prospects

Updated Category News Views 200

Wells Fargo maintained its Overweight rating on monday.com Ltd. (NASDAQ: MNDY) back in 2024, setting a price target of $315. This ain't just some wishful thinking; it was backed by compelling observations about the company's performance and the surrounding market dynamics. As we pulled into Q3, demand for monday.com’s offerings beat expectations by 4%. With partners...

Continue Reading
Syantra, Inc. Partners to Enhance Breast Cancer Detection in NZ

Updated Category News Views 153

Syantra, Inc. Partners with Breast Cancer Foundation NZ Syantra, Inc., a pioneering force in precision biotechnology dedicated to early cancer detection, has announced an exciting partnership with Breast Cancer Foundation NZ. This collaboration is a pivotal move to expand the reach of Syantra's innovative cancer detection platform, Onco-ID™, specifically its first test,...

Continue Reading
Discover Technics' SC-CX700: The Ultimate Wireless Speaker

Updated Category News Views 81

Introducing the SC-CX700 Wireless Speaker System Hi-Fi enthusiasts have something to celebrate with the launch of Technics' SC-CX700 Wireless Speaker System, a remarkable innovation unveiled at a major electronics trade show. This new system merges Technics' rich audio legacy with contemporary design, offering an exceptional music experience that resonates profoundly with...

Continue Reading
Nepsis, Inc. Welcomes Derek Malmquist as VP of Marketing

Updated Category News Views 145

Nepsis, Inc. Welcomes Derek Malmquist as Vice President of Marketing Nepsis, Inc., a leading financial advisor and investment management firm, has announced the appointment of Derek Malmquist as the new Vice President of Marketing. This strategic move aims to elevate Nepsis' communication strategy and shine a light on the integrated solutions it provides to clients,...

Continue Reading
Quantiphi Achieves 2025 AWS Partner of the Year Recognition

Updated Category News Views 194

Quantiphi Celebrates Major Achievement at AWS re:Invent 2025 Las Vegas welcomed the announcement that Quantiphi, a leader in digital engineering with a focus on artificial intelligence, has been honored with the 2025 Amazon Web Services (AWS) Public Sector Global GenAI Consulting Partner of the Year award. This prestigious recognition highlights Quantiphi's commitment to...

Continue Reading